Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.87 USD
−32.67 M USD
3.42 M USD
43.48 K
About OpGen, Inc.
Sector
CEO
Hon Jian Tan
Website
Headquarters
Rockville
Founded
2001
FIGI
BBG0087J22V2
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OPGN is 1.54 USD — it has increased by 7.69% in the past 24 hours. Watch OpGen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange OpGen, Inc. stocks are traded under the ticker OPGN.
OPGN stock has fallen by −21.03% compared to the previous week, the month change is a −6.67% fall, over the last year OpGen, Inc. has showed a −96.62% decrease.
OPGN reached its all-time high on May 6, 2015 with the price of 54,400,000,000.00 USD, and its all-time low was 1.40 USD and was reached on Nov 12, 2024. View more price dynamics on OPGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OPGN stock is 7.36% volatile and has beta coefficient of 0.09. Track OpGen, Inc. stock price on the chart and check out the list of the most volatile stocks — is OpGen, Inc. there?
Today OpGen, Inc. has the market capitalization of 15.81 M, it has decreased by −6.94% over the last week.
Yes, you can track OpGen, Inc. financials in yearly and quarterly reports right on TradingView.
OpGen, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
OPGN net income for the last quarter is 8.93 M USD, while the quarter before that showed −1.58 M USD of net income which accounts for 666.57% change. Track more OpGen, Inc. financial stats to get the full picture.
No, OPGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OpGen, Inc. EBITDA is −5.60 M USD, and current EBITDA margin is −420.38%. See more stats in OpGen, Inc. financial statements.
Like other stocks, OPGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OpGen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OpGen, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OpGen, Inc. stock shows the sell signal. See more of OpGen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.